Autolus Competitors and Similar CompaniesClear all
Autolus's competitors and similar companies include Cellink, Longboard Pharmaceuticals, Aquinnah Pharmaceuticals and Roquette.
 Autolus Autolus Therapeutics is a private biopharmaceutical company, focused on the development and commercialization of engineered T-cell immunotherapy products. |  Cellink CELLINK is a company that develops bioprinting technologies that allow researchers to 3D print human organs and tissue models of pharmaceutical and cosmetic products. |  Longboard Pharmaceuticals Longboard Pharmaceuticals, Inc. (Longboard) is a biopharmaceutical company focused on developing transformative medicines for neurological diseases. |  Aquinnah Pharmaceuticals Aquinnah Pharmaceuticals is a company that specializes in developing drugs for neurodegenerative diseases. | ||
Founding Date | Founding Date 2014 | Founding Date 2016 | Founding Date 2020 | Founding Date 2014 | Founding Date 1933 |
Type | Type Public | Type Subsidiary | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations London, GB HQ London, GB | Locations Göteborg, SE HQ Dardilly, FR Kyoto, JP Göteborg, SE Brighton, GB Blacksburg, US Boston, US | Locations San Diego, US HQ San Diego, US | Locations Cambridge, US HQ | |
Employees | Employees 647 | Employees 851% decrease | Employees 5056% increase | Employees 17 | Employees 5,5622% increase |
Valuation ($) | Valuation ($) 1.2 b | Valuation ($) N/A | Valuation ($) 2.3 b | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $75.4m (FY, 2025) | Revenue (est.) kr74.2m (FY, 2021) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods $86.6m (FY, 2025) | Cost of goods kr40.2m (FY, 2021) | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit ($10.7m) (FY, 2025) | Gross profit kr34.1m (FY, 2021) | Gross profit N/A | Gross profit N/A | Gross profit N/A |
Net income | Net income ($287.5m) (FY, 2025) | Net income (kr27.4m) (FY, 2021) | Net income ($54.4m) (FY, 2023) | Net income N/A | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 281.7m | Total funding raised $ 4.1m | Total funding raised $ 56m | Total funding raised $ 19.8m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Cellink
HQ
Göteborg, SE
CELLINK is a company that develops bioprinting technologies that allow researchers to 3D print human organs and tissue models of pharmaceutical and cosmetic products.
View companyLongboard Pharmaceuticals
HQ
San Diego, US
Employees
50
Longboard Pharmaceuticals, Inc. (Longboard) is a biopharmaceutical company focused on developing transformative medicines for neurological diseases.
View companyAquinnah Pharmaceuticals
HQ
Cambridge, US
Employees
17
Aquinnah Pharmaceuticals is a company that specializes in developing drugs for neurodegenerative diseases.
View company
Roquette
HQ
Lestrem, FR
Employees
5,562↑ 2% increase
Roquette is a provider of plant-based ingredients.
View company